drugset / Trial / NCT04460001
Injection of Ranibizumab Versus Combination of Ranibizumab and Triamcinolone Acetate for (CRVO)
RandomizedParallel-groupQuadruple-blindTreatment
Summary
To compare the clinical effectiveness of ranibizumab and combination of ranibizumab and triamcinolone for the treatment of macular oedema secondary to CRVO
Timeline
- Start
- 2019-05-16
- Primary completion
- 2021-08-01
- Completion
- 2021-12-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Ranibizumab | Monoclonal antibody | — | Intravitreal |
| Comparator | Triamcinolone | Other / unclassified | — | Intravitreal |
Indications
No indication recorded.